Turley A J, Murray S, Thambyrajah J
Cardiothoracic Division, The James Cook University Hospital, Marton Road, Middlesbrough TS4 3BW, UK.
Emerg Med J. 2008 Jan;25(1):46-8. doi: 10.1136/emj.2007.051227.
Although serious adverse events following adenosine administration are rare, it should only be administered in an environment where continuous ECG monitoring and emergency resuscitation equipment are available. The case report describes the development of pre-excited atrial fibrillation in a 31-year-old woman with Wolff-Parkinson-White syndrome following the administration of adenosine. She had previously been fit and well and was admitted to the coronary care unit with a 2 h history of regular palpitations. A 12-lead ECG showed a narrow QRS complex tachycardia. Carotid sinus massage was unsuccessful in terminating the tachycardia and the patient subsequently received rapid boluses of intravenous adenosine. The cardiac rhythm degenerated into atrial fibrillation with ventricular pre-excitation following 12 mg adenosine.
尽管腺苷给药后严重不良事件罕见,但仅应在具备连续心电图监测和急救复苏设备的环境中给药。该病例报告描述了一名患有 Wolff-Parkinson-White 综合征的 31 岁女性在接受腺苷治疗后发生预激性心房颤动的情况。她之前身体健康,因有 2 小时规律心悸病史入住冠心病监护病房。12 导联心电图显示窄 QRS 波群心动过速。颈动脉窦按摩未能终止心动过速,患者随后接受了快速静脉推注腺苷。在给予 12 毫克腺苷后,心律恶化为伴有心室预激的心房颤动。